FranciscoJavierCervantesMD

PubMed

• 41 citations
  Electron shuttling mediated by humic substances fuels anaerobic methane oxidation and carbon burial in wetland sediments
  Edgardo I. Valenzuela, Karen A. Avendaño, Nagamani Balagurusamy, Sonia Arriaga, Cesar Nieto-Delgado, Frederic Thalasso, Francisco J. Cervantes> ;The Science of the Total Environment. 2019 Feb 10
• 13 citations
  Graphene oxide triggers mass transfer limitations on the methanogenic activity of an anaerobic consortium with a particulate substrate.
  J. Iván Bueno-López, J. Rene Rangel-Mendez, Felipe Alatriste-Mondragón, Fátima Pérez-Rodríguez, Virginia Hernández-Montoya, Francisco J. Cervantes> ;Chemosphere. 2018 Nov 1
• 14 citations
  Novel application of magnetic nano-carbon composite as redox mediator in the reductive biodegradation of iopromide in anaerobic continuous systems
  Eduardo Toral-Sánchez, Jose Rene Rangel-Mendez, Robert H. Hurt, Juan A. Ascacio Valdés, Cristóbal N. Aguilar, Francisco J. Cervantes> ;Applied Microbiology and Biotechnology. 2018 Jul 30
• 41 citations
  Anaerobic ammonium oxidation linked to sulfate and ferric iron reduction fuels nitrogen loss in marine sediments.
  E. Emilia Rios-Del Toro, Edgardo I. Valenzuela, Nguyen E. López-Lozano, M. Guadalupe Cortés-Martínez, Miguel A. Sánchez-Rodríguez, Omar Calvario-Martínez, Salvador Sán...> ;Biodegradation. 2018 Jun 11
• 201 citations
  SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis.
  Ruben A. Mesa, Jean-Jacques Kiladjian, John Catalano, Timothy Devos, Miklos Egyed, Andrzei Hellmann, Donal McLornan, Kazuya Shimoda, Elliott F. Winton, Wei Deng, Ronal...> ;Journal of Clinical Oncology. 2017 Sep 20
• 22 citations
  Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis.
  Juan Carlos Hernández-Boluda, Juan-Gonzalo Correa, Regina Garcia-Delgado, Joaquin Martinez-Lopez, Alberto Alvarez-Larrán, María-Laura Fox, Valentín García-Gutiérrez, M...> ;European Journal of Haematology. 2017 Jan 19
• 77 citations
  Does ruxolitinib prolong the survival of patients with myelofibrosis
  Francisco Cervantes, Arturo Pereira> ;Blood. 2017 Feb 16
• 23 citations
  Tailoring partially reduced graphene oxide as redox mediator for enhanced biotransformation of iopromide under methanogenic and sulfate-reducing conditions.
  Eduardo Toral-Sánchez, J. Rene Rangel-Mendez, Juan A. Ascacio Valdés, Cristóbal N. Aguilar, Francisco J. Cervantes> ;Bioresource Technology. 2017 Jan 1
• 25 citations
  Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response
  Francisco Cervantes, Juan-Gonzalo Correa, Isabel Pérez, Valentín García-Gutiérrez, Sara Redondo, Dolors Colomer, Antonio Jiménez-Velasco, J.L. Steegmann, Fermín Sánche...> ;Annals of Hematology. 2017 Jan 1
• Driver mutations' effect in secondary myelofibrosis: An international multicenter study based on 781 patients.
  Passamonti F, Mora B, Giorgino T, Guglielmelli P, Cazzola M, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F,...> ;Leukemia. 2016-11-25
• Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.
  Marchetti M, Barosi G, Cervantes F, Birgegård G, Griesshammer M, Harrison C, Hehlmann R, Kiladjian J, Kröger N, McMullin MF, Passamonti F, Vannucchi A, Barbui T> ;Leukemia. 2016-11-18
• High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists.
  De Stefano V, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Rossi E, Betti S, Nichel...> ;Leukemia. 2016-10-01
• 44 citations
  Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease
  Holly L. Geyer, Robyn M. Scherber, Heidi E. Kosiorek, Amylou C. Dueck, Jean-Jacques Kiladjian, Zhijian Xiao, Stefanie Slot, Sonja Zweegman, Federico Sackmann, Ana Kerg...> ;Journal of Clinical Oncology. 2016 Jan 10
• Associations between gender, disease features and symptom burden in the MPN population: An analysis by the MPN QOL International Working Group.
  Geyer HL, Kosiorek H, Dueck AC, Scherber R, Slot S, Zweegman S, Te Boekhorst PA, Senyak Z, Schouten HC, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl HL, ...> ;Haematologica. 2016-08-18
• Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.
  Harrison CN, Vannucchi AM, Kiladjian J, Al-Ali HK, Gisslinger H, Knoops L, Cervantes F, Jones MM, Sun K, McQuitty M, Stalbovskaya V, Gopalakrishna P, Barbui T> ;Leukemia. 2016-08-01
• 102 citations
  Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation
  Alberto Alvarez-Larrán, Arturo Pereira, Paola Guglielmelli, Juan Carlos Hernández-Boluda, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marín, Alimam Samah, Martin Griess...> ;Haematologica. 2016 May 12
• 14 citations
  The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
  Holly L. Geyer, Bjorn Andreasson, Heidi E. Kosiorek, Amylou C. Dueck, Robyn M. Scherber, Kari A. Martin, Kristina A. Butler, Claire N. Harrison, Deepti Radia, Francisc...> ;Cancer. 2016 Jun 15
• 24 citations
  Immobilization of metal-humic acid complexes in anaerobic granular sludge for their application as solid-phase redox mediators in the biotransformation of iopromide in...
  Aracely S. Cruz-Zavala, Aurora M. Pat-Espadas, J. Rene Rangel-Mendez, Luis F. Chazaro-Ruiz, Juan A. Ascacio-Valdés, Cristóbal N. Aguilar, Francisco J. Cervantes> ;Bioresource Technology. 2016 May 1
• 30 citations
  Coupling between anammox and autotrophic denitrification for simultaneous removal of ammonium and sulfide by enriched marine sediments.
  E. Emilia Rios-Del Toro, Francisco J. Cervantes> ;Biodegradation. 2016 Mar 19
• 102 citations
  Myeloproliferative neoplasms and inflammation: Whether to target the malignant clone or the inflammatory process or both
  Steffen Koschmieder, Tariq I. Mughal, Hans Carl Hasselbalch, G Barosi, Peter Valent, J J Kiladjian, Georg Jeryczynski, Heinz Gisslinger, Jonas S. Jutzi, Heike L. Pahl,...> ;Leukemia. 2016 Feb 8
• 9 citations
  Recovery of palladium(II) by methanogenic granular sludge.
  Aurora M. Pat-Espadas, Jim A. Field, Lila Otero-Gonzalez, Elías Razo-Flores, Francisco J. Cervantes, Reyes Sierra-Alvarez> ;Chemosphere. 2016 Feb 1
• 12 citations
  Immobilization of biogenic Pd(0) in anaerobic granular sludge for the biotransformation of recalcitrant halogenated pollutants in UASB reactors.
  Aurora M. Pat-Espadas, Elías Razo-Flores, J. Rene Rangel-Mendez, Juan A. Ascacio-Valdés, Cristóbal N. Aguilar, Francisco J. Cervantes> ;Applied Microbiology and Biotechnology. 2016 Feb 1
• 14 citations
  Long-term results of prednisone treatment for the anemia of myelofibrosis
  Juan Carlos Hernández-Boluda, Alejandra Martínez-Trillos, Valentín García-Gutiérrez, Francisca Ferrer-Marín, Blanca Xicoy, Alberto Alvarez-Larrán, Ana Kerguelen, Pere ...> ;Leukemia & Lymphoma. 2016 Jan 1
• 177 citations
  Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
  Markus Pfirrmann, Michele Baccarani, Susanne Saussele, Joelle Guilhot, Francisco Cervantes, Gert J. Ossenkoppele, Verena S. Hoffmann, Fausto Castagnetti, Joerg Hasford...> ;Leukemia. 2016 Jan 1
• 84 citations
  Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
  Alessandro M. Vannucchi, T Barbui, Francisco Cervantes, Claire N. Harrison, Jean-Jacques Kiladjian, N Kröger, Juergen Thiele, Christian Buske> ;Annals of Oncology. 2015 Sep 1
• Join now to see all